QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of | (I.R.S. Employer Identification No.) | |
incorporation or organization) | ||
|
||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
|
|
| ||
☒ |
☐ Accelerated filer | ☐ Non-accelerated filer |
Page |
||||||
1 |
||||||
Item 1. | ||||||
2 | ||||||
3 | ||||||
4 | ||||||
5 | ||||||
6 | ||||||
Item 2. | 18 | |||||
18 | ||||||
19 | ||||||
21 | ||||||
23 | ||||||
24 | ||||||
26 | ||||||
28 | ||||||
Item 3. | 32 | |||||
Item 4. | 32 | |||||
Item 1. | 33 | |||||
Item 1A. | 33 | |||||
Item 2. | 34 | |||||
Item 3. | 34 | |||||
Item 4. | 34 | |||||
Item 5. | 35 | |||||
Item 6. | 35 | |||||
Signatures | 36 | |||||
Exhibits |
● | COVID-19 |
● | International Operations – worldwide and local economic and market conditions; changes in political conditions; and fluctuations in foreign currency exchange rates and other risks associated with foreign operations, including in emerging markets |
● | Our Business – changes in our markets due to competitive conditions, technological developments, environmental standards, laws and regulations, and customer preferences; fluctuations in demand affecting sales to customers; execution and integration of acquisitions, including the acquisition of Vestcom; selling prices; fluctuations in the cost and availability of raw materials and energy; the impact of competitive products and pricing; customer and supplier concentrations or consolidations; financial condition of distributors; outsourced manufacturers; product and service quality; timely development and market acceptance of new products, including sustainable or sustainably-sourced products; investment in development activities and new production facilities; successful implementation of new manufacturing technologies and installation of manufacturing equipment; our ability to generate sustained productivity improvement; our ability to achieve and sustain targeted cost reductions; and collection of receivables from customers |
● | The Vestcom Acquisition – risks related to future opportunities and plans for the combined company, including the uncertainty of expected future financial performance and results of the combined company; unknown liabilities; and the possibility that, if we do not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by financial analysts or investors, the market price of our common stock could decline |
● | Income Taxes – fluctuations in tax rates; changes in tax laws and regulations, and uncertainties associated with interpretations of such laws and regulations; retention of tax incentives; outcome of tax audits; and the realization of deferred tax assets |
● | Information Technology – disruptions in information technology systems, including cyber-attacks or other intrusions to network security; successful installation of new or upgraded information technology systems; and data security breaches |
● | Human Capital – recruitment and retention of employees; fluctuations in employee benefit costs; and collective labor arrangements |
● | Our Indebtedness – credit risks; our ability to obtain adequate financing arrangements and maintain access to capital; volatility of financial markets; fluctuations in interest rates; and compliance with our debt covenants |
● | Ownership of Our Stock – potential significant variability of our stock price and amounts of future dividends and share repurchases |
● | Legal and Regulatory Matters – protection and infringement of intellectual property and impact of legal and regulatory proceedings, including with respect to environmental, health and safety, anti-corruption and trade compliance |
● | Other Financial Matters – fluctuations in pension costs and goodwill impairment |
ITEM 1. |
FINANCIAL STATEMENTS |
(Dollars in millions, except per share amount) |
October 2, 2021 |
January 2, 2021 |
||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ |
$ |
||||||
Trade accounts receivable, less allowances of $ |
||||||||
Inventories, net |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
Property, plant and equipment, net |
||||||||
Goodwill |
||||||||
Other intangibles resulting from business acquisitions, net |
||||||||
Deferred tax assets |
||||||||
Other assets |
||||||||
$ |
$ |
|||||||
|
||||||||
Liabilities and Shareholders’ Equity |
||||||||
Current liabilities: |
||||||||
Short-term borrowings and current portion of long-term debt and finance leases |
$ |
$ |
||||||
Accounts payable |
||||||||
Accrued payroll and employee benefits |
||||||||
Other current liabilities |
||||||||
Total current liabilities |
||||||||
Long-term debt and finance leases |
||||||||
Long-term retirement benefits and other liabilities |
||||||||
Deferred tax liabilities and income taxes payable |
||||||||
Commitments and contingencies (see Note 12) |
||||||||
Shareholders’ equity: |
||||||||
Common stock, $ October 2, 2021 and January 2, 2021; issued – October 2, 2021 and January 2, 2021; outstanding – |
||||||||
Capital in excess of par value |
||||||||
Retained earnings |
||||||||
Treasury stock at cost, |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Total shareholders’ equity |
||||||||
$ |
$ |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions, except per share amounts) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
Net sales |
$ |
$ |
$ |
$ |
||||||||||||
Cost of products sold |
||||||||||||||||
Gross profit |
||||||||||||||||
Marketing, general and administrative expense |
||||||||||||||||
Other expense (income), net |
||||||||||||||||
Interest expense |
||||||||||||||||
Other non-operating expense (income), net |
( |
) | ( |
) |
( |
) | ||||||||||
Income before taxes |
||||||||||||||||
Provision for (benefit from) income taxes |
||||||||||||||||
Equity method investment (losses) gains |
( |
) | ( |
) |
( |
) | ( |
) | ||||||||
Net income |
$ |
$ |
$ |
$ |
||||||||||||
|
||||||||||||||||
Per share amounts: |
||||||||||||||||
Net income per common share |
$ |
$ |
$ |
$ |
||||||||||||
Net income per common share, assuming dilution |
$ |
$ |
$ |
$ |
||||||||||||
|
||||||||||||||||
Weighted average number of shares outstanding: |
||||||||||||||||
Common shares |
||||||||||||||||
Common shares, assuming dilution |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
Net income |
$ |
$ |
$ |
$ |
||||||||||||
Other comprehensive income (loss), net of tax: |
||||||||||||||||
Foreign currency translation |
( |
) | ||||||||||||||
Pension and other postretirement benefits |
||||||||||||||||
Cash flow hedges |
( |
) |
( |
) | ||||||||||||
Other comprehensive income (loss), net of tax |
( |
) | ||||||||||||||
Total comprehensive income, net of tax |
$ |
$ |
$ |
$ |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Operating Activities |
||||||||
Net income |
$ |
$ |
||||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation |
||||||||
Amortization |
||||||||
Provision for credit losses and sales returns |
||||||||
Stock-based compensation |
||||||||
Pension plan settlement loss |
— |
|||||||
Deferred taxes and other non-cash taxes |
( |
) |
||||||
Other non-cash expense and loss (income and gain), net |
||||||||
Changes in assets and liabilities and other adjustments |
( |
) | ( |
) | ||||
Net cash provided by operating activities |
||||||||
|
||||||||
Investing Activities |
||||||||
Purchases of property, plant and equipment |
( |
) | ( |
) | ||||
Purchases of software and other deferred charges |
( |
) | ( |
) | ||||
Proceeds from sales of property, plant and equipment |
||||||||
Proceeds from insurance and sales (purchases) of investments, net |
||||||||
Proceeds from sale of product line |
— |
|||||||
Payments for acquisitions, net of cash acquired, and investments in businesses |
( |
) | ( |
) | ||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
|
||||||||
Financing Activities |
||||||||
Net increase (decrease) in borrowings with maturities of three months or less |
( |
) | ||||||
Additional borrowings under revolving credit facility |
— |
|||||||
Repayments of revolving credit facility |
— |
( |
) | |||||
Additional long-term borrowings |
||||||||
Repayments of long-term debt and finance leases |
( |
) | ( |
) | ||||
Dividends paid |
( |
) | ( |
) | ||||
Share repurchases |
( |
) | ( |
) | ||||
Net (tax withholding) proceeds related to stock-based compensation |
( |
) | ( |
) | ||||
Net cash provided by (used in) financing activities |
( |
) | ||||||
|
||||||||
Effect of foreign currency translation on cash balances |
( |
) | ||||||
Increase (decrease) in cash and cash equivalents |
( |
) |
||||||
Cash and cash equivalents, beginning of year |
||||||||
Cash and cash equivalents, end of period |
$ |
$ |
(In millions) |
||||
Cash and cash equivalents |
$ |
|||
Trade accounts receivable |
||||
Other current assets |
||||
Property, plant and equipment |
||||
Goodwill |
||||
Other intangibles resulting from business acquisition |
||||
Other assets |
||||
Total assets |
||||
C urrent liabilities |
||||
Other liabilities |
||||
Deferred tax liabilities |
||||
Total liabilities |
||||
Net assets acquired |
$ |
(In millions) |
Label and Graphic Materials |
Retail Branding and Information Solutions |
Industrial and Healthcare Materials |
Total |
||||||||||||
Goodwill as of January 2, 2021 |
$ | $ | $ | $ | |
|||||||||||
Acquisitions (1) |
— | |||||||||||||||
Acquisition adjustment (2) |
— | — | ||||||||||||||
Translation adjustments |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Goodwill as of October 2, 2021 |
$ | $ | $ | $ |
(1) |
Goodwill acquired related to the acquisitions of Vestcom, JDC and ZippyYum. We expect nearly all of the recognized goodwill related to the Vestcom and JDC acquisitions not to be deductible for income tax purposes and the recognized goodwill related to the ZippyYum acquisition to be deductible for income tax purposes. |
(2) |
Measurement period adjustment related to the finalization of the purchase price allocation for the acquisition of ACPO, Ltd. completed in December 2020. |
Amount (in millions) |
Amortization period (in years) |
|||||||
Customer relationships |
$ | |||||||
Patented and other developed technology |
||||||||
Trade names and trademarks (1) |
N/A |
(1) |
Acquired trade names and trademarks associated with the Vestcom acquisition were not subject to amortization as they were classified as indefinite-lived intangible assets. |
(In millions) |
Accrual at January 2, 2021 |
Charges, Net of Reversals |
Cash Payments |
Non-cash Impairment |
Foreign Currency Translation |
Accrual at October 2, 2021 |
||||||||||||||||||
2019/2020 Actions |
||||||||||||||||||||||||
Severance and related costs |
$ | $ | $ | ( |
) | $ | $ | ( |
) | $ | ||||||||||||||
Asset impairment |
( |
) | ||||||||||||||||||||||
Lease cancellation costs |
|
|
|
|
|
|
|
|
|
|
( |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
$ | $ | $ | ( |
) | $ | ( |
) | $ | ( |
) | $ |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
Restructuring charges, net of reversals, by reportable segment and Corporate |
||||||||||||||||
Label and Graphic Materials |
$ | $ | $ | $ | ||||||||||||
Retail Branding and Information Solutions |
||||||||||||||||
Industrial and Healthcare Materials |
||||||||||||||||
Corporate |
( |
) | ||||||||||||||
Total |
$ | $ | $ | $ |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(Dollars in millions) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
Income before taxes |
$ | $ | $ | $ | ||||||||||||
Provision for (benefit from) income taxes |
||||||||||||||||
Effective tax rate |
% | % | % | % |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions, except per share amounts) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
(A) Net income |
$ | $ | $ | $ | ||||||||||||
(B) Weighted average number of common shares outstanding |
||||||||||||||||
Dilutive shares (additional common shares issuable under stock-based awards) |
||||||||||||||||
(C) Weighted average number of common shares outstanding, assuming dilution |
||||||||||||||||
Net income per common share: (A) ÷ (B) |
$ | $ | $ | $ | ||||||||||||
Net income per common share, assuming dilution: (A) ÷ (C) |
$ | $ | $ | $ |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
Common stock issued, $1 par value per share |
$ | $ | $ | $ | ||||||||||||
Capital in excess of par value |
||||||||||||||||
Beginning balance |
$ | $ | $ | $ | ||||||||||||
Issuance of shares under stock-based compensation plans (1) |
( |
) | ( |
) | ||||||||||||
Ending balance |
$ | $ | $ | $ | ||||||||||||
Retained earnings |
||||||||||||||||
Beginning balance |
$ | $ | $ | $ | ||||||||||||
Net income |
||||||||||||||||
Issuance of shares under stock-based compensation plans (1) |
( |
) | ( |
) | ||||||||||||
Contribution of shares to 401(k) Plan (1) |
||||||||||||||||
Dividends |
( |
) |
( |
) | ( |
) | ( |
) | ||||||||
Ending balance |
$ | $ | $ | $ | ||||||||||||
Treasury stock at cost |
||||||||||||||||
Beginning balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Repurchase of shares for treasury |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Issuance of shares under stock-based compensation plans (1) |
||||||||||||||||
Contribution of shares to 401(k) Plan (1) |
||||||||||||||||
Ending balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Accumulated other comprehensive loss |
||||||||||||||||
Beginning balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss), net of tax |
( |
) | ||||||||||||||
Ending balance |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) |
(1) |
We fund a portion of our employee-related expenses using shares of our common stock held in treasury. We reduce capital in excess of par value based on the grant date fair value of the awards vested and record net gains or losses associated with using treasury shares to retained earnings. |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
|||||||||||||
Dividends per common share |
$ | $ | $ | $ |
(In millions) |
Foreign Currency Translation |
Pension and Other Postretirement Benefits |
Cash Flow Hedges |
Total |
||||||||||||
Balance as of January 2, 2021 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss) before reclassifications, net of tax |
— | |||||||||||||||
Reclassifications to net income, net of tax |
— | ( |
) | |||||||||||||
Other comprehensive income (loss), net of tax |
||||||||||||||||
Balance as of October 2, 2021 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) |
(In millions) |
Foreign Currency Translation |
Pension and Other Postretirement Benefits |
Cash Flow Hedges |
Total |
||||||||||||
Balance as of December 28, 2019 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Other comprehensive income (loss) before reclassifications, net of tax |
( |
) | — | ( |
) | ( |
) | |||||||||
Reclassifications to net income, net of tax |
— | |||||||||||||||
Other comprehensive income (loss), net of tax |
( |
) | ( |
) | ( |
) | ||||||||||
Balance as of September 26, 2020 |
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) |
Fair Value Measurements Using |
||||||||||||||||
(In millions) |
Total |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
||||||||||||
Assets |
||||||||||||||||
Investments |
$ | $ | $ | $ | — | |||||||||||
Derivative assets |
— | |||||||||||||||
Bank drafts |
— | — | ||||||||||||||
Liabilities |
||||||||||||||||
Cross-currency swap |
$ | $ | — | $ | $ | — | ||||||||||
Derivative liabilities |
— | — | ||||||||||||||
Contingent consideration liabilities |
— | — |
Fair Value Measurements Using |
||||||||||||||||
(In millions) |
Total |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
||||||||||||
Assets |
||||||||||||||||
Investments |
$ | $ | $ | $ | — | |||||||||||
Derivative assets |
— | |||||||||||||||
Bank drafts |
— | — | ||||||||||||||
Liabilities |
||||||||||||||||
Cross-currency swap |
$ | $ | — | $ | $ | — | ||||||||||
Derivative liabilities |
— |
(In millions) |
||||
Acquisition |
$ | |||
Payments |
( |
) | ||
Balance at October 2, 2021 |
$ | |
(In millions) |
||||
Balance at January 2, 2021 |
$ | |||
Charges, net of reversals |
||||
Payments |
( |
) | ||
Balance at October 2, 2021 |
$ | |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
Net sales to unaffiliated customers |
||||||||||||||||
Label and Graphic Materials: |
||||||||||||||||
U.S. |
$ | $ | $ | $ | ||||||||||||
Europe, Middle East and North Africa |
||||||||||||||||
Asia |
||||||||||||||||
Latin America |
||||||||||||||||
Other international |
||||||||||||||||
Total Label and Graphic Materials |
||||||||||||||||
Retail Branding and Information Solutions: |
||||||||||||||||
Apparel |
||||||||||||||||
Identification Solutions (1) |
||||||||||||||||
Total Retail Branding and Information Solutions |
||||||||||||||||
Industrial and Healthcare Materials |
||||||||||||||||
Net sales to unaffiliated customers |
$ | $ | $ | $ |
(1) |
Previously referred to as Printer Solutions |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
October 2, 2021 |
September 26, 2020 |
||||||||||||
Intersegment sales |
||||||||||||||||
Label and Graphic Materials |
$ | $ | $ | $ | ||||||||||||
Retail Branding and Information Solutions |
||||||||||||||||
Industrial and Healthcare Materials |
||||||||||||||||
Intersegment sales |
$ | $ | $ | $ | ||||||||||||
Income before taxes |
||||||||||||||||
Label and Graphic Materials |
$ | $ | $ | $ | ||||||||||||
Retail Branding and Information Solutions |
||||||||||||||||
Industrial and Healthcare Materials |
||||||||||||||||
Corporate expense |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Interest expense |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Other non-operating expense (income), net |
( |
) | ||||||||||||||
Income before taxes |
$ | $ | $ | $ | ||||||||||||
Other expense (income), net, by reportable segment and Corporate |
||||||||||||||||
Label and Graphic Materials |
$ | $ | $ | ( |
) | $ | ||||||||||
Retail Branding and Information Solutions |
||||||||||||||||
Industrial and Healthcare Materials |
||||||||||||||||
Corporate |
( |
) | ||||||||||||||
Other expense (income), net |
$ | $ | $ | $ | ||||||||||||
Other expense (income), net, by type |
||||||||||||||||
Restructuring charges: |
||||||||||||||||
Severance and related costs |
$ | $ | $ | $ | ||||||||||||
Asset impairment charges and lease cancellation costs |
||||||||||||||||
Other items: |
||||||||||||||||
Transaction and related costs |
||||||||||||||||
Loss on sale of assets, net |
||||||||||||||||
(Gain) loss on investments |
( |
) | ( |
) | ||||||||||||
Gain on sale of product line |
( |
) | ( |
) | ||||||||||||
Outcomes of legal proceedings, net (1) |
( |
) | ||||||||||||||
Other expense (income), net |
$ | $ | $ | $ |
(1) |
First nine months of 2021 include an indirect tax credit based on a Brazilian Federal Supreme Court ruling in our favor in the amount of $ |
(In millions) |
October 2, 2021 |
January 2, 2021 |
||||||
Raw materials |
$ | $ | ||||||
Work-in-progress |
||||||||
Finished goods |
||||||||
Inventories, net |
$ | $ |
(In millions) |
October 2, 2021 |
January 2, 2021 |
||||||
Property, plant and equipment |
$ | $ | ||||||
Accumulated depreciation |
( |
) | ( |
) | ||||
Property, plant and equipment, net |
$ | $ |
The activity related to our allowance for credit losses is shown below. |
||||||||
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Beginning balance |
$ | $ | ||||||
(Reversal of) provision for credit losses (1) |
( |
) | ||||||
Amounts written off |
( |
) | ( |
) | ||||
Other, including foreign currency translation |
||||||||
Ending balance |
$ | $ |
(1) |
For the nine months ended September 26, 2020, our provision for credit losses reflected impacts on customers as a result of COVID-19. |
● | Sales change ex. currency |
● | Organic sales change |
● | Free cash flow |
● | Operational working capital as a percentage of annualized current quarter net sales held-for-sale day-to-day |
Three Months Ended October 2, 2021 |
Nine Months Ended October 2, 2021 |
|||||||
Reported sales change |
20 | % | 25 | % | ||||
Foreign currency translation Extra week impact |
|
(3 — |
) |
|
(5 (1 |
) ) | ||
Sales change ex. currency (1) |
17 | 19 | ||||||
Acquisitions and product line divestitures |
(3 | ) | (2 | ) | ||||
Organic sales change (1) |
14 | % | 17 | % |
(1) |
Totals may not sum due to rounding |
● | Higher volume/mix |
● | Favorable currency translation |
● | Benefits from productivity initiatives, including savings from restructuring actions, net of transition costs |
● | Benefit from the Brazil indirect tax credit |
● | Lower allowances for credit losses |
● | Higher employee-related costs |
● | The impact of prior-year temporary cost reduction actions |
● | Higher tax provision |
● | Net impact of higher selling prices, higher raw material costs, and higher freight costs |
● | Contingent liability related to patent infringement litigation |
● | Higher transaction and related costs |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net cash provided by operating activities |
$ | 762.8 | $ | 441.8 | ||||
Purchases of property, plant and equipment |
(130.6 | ) | (91.7 | ) | ||||
Purchases of software and other deferred charges |
(9.8 | ) | (13.8 | ) | ||||
Proceeds from sales of property, plant and equipment |
1.1 | .2 | ||||||
Proceeds from insurance and sales (purchases) of investments, net |
1.2 | 5.2 | ||||||
Payments for certain acquisition-related transaction costs |
14.5 | — | ||||||
Free cash flow |
$ | 639.2 | $ | 341.7 |
● | We expect net sales to increase by approximately 20%, including an increase of approximately 3.5% from the effect of foreign currency translation and a decrease of approximately 1.5% related to the calendar shift resulting from the extra week in 2020. |
● | We expect closed acquisitions to benefit operating income. |
● | Based on recent exchange rates, we expect foreign currency translation to increase our operating income by approximately $30 million. |
● | We expect incremental savings from restructuring actions, net of transition costs, of approximately $60 million. |
● | We expect the pace of our investments in our businesses to accelerate throughout the year. |
● | We expect our full year effective tax rate to be in the mid-twenty percent range. |
● | We expect net cash provided by operating activities and free cash flow to increase. |
Three Months Ended |
||||||||
(In millions, except percentages) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales |
$ | 2,071.8 | $ | 1,729.1 | ||||
Cost of products sold |
1,517.4 | 1,244.9 | ||||||
Gross profit |
554.4 | 484.2 | ||||||
Marketing, general and administrative expense |
296.9 | 258.3 | ||||||
Other expense (income), net |
16.0 | 12.4 | ||||||
Interest expense |
18.0 | 15.6 | ||||||
Other non-operating expense (income), net |
(.9 | ) | .1 | |||||
Income before taxes |
$ | 224.4 | $ | 197.8 | ||||
Gross profit margin |
26.8 | % | 28.0 | % |
Three Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Other expense (income), net, by type |
||||||||
Restructuring charges: |
||||||||
Severance and related costs |
$ | 1.1 | $ | 6.5 | ||||
Asset impairment charges and lease cancellation costs |
1.3 | 4.4 | ||||||
Other items: |
||||||||
Transaction and related costs |
19.4 | — | ||||||
(Gain) loss on investments |
(4.9 | ) | 1.5 | |||||
Gain on sale of product line |
(.9 | ) | — | |||||
Other expense (income), net |
$ | 16.0 | $ | 12.4 |
Three Months Ended |
||||||||
(In millions, except per share amounts and percentages) |
October 2, 2021 |
September 26, 2020 |
||||||
Income before taxes |
$ | 224.4 | $ | 197.8 | ||||
Provision for (benefit from) income taxes |
59.2 | 46.3 | ||||||
Equity method investment (losses) gains |
(1.1 | ) | (1.0 | ) | ||||
Net income |
$ | 164.1 | $ | 150.5 | ||||
Per share amounts: |
||||||||
Net income per common share |
$ | 1.98 | $ | 1.80 | ||||
Net income per common share, assuming dilution |
1.96 | 1.79 | ||||||
Effective tax rate |
26.4 | % | 23.4 | % |
Three Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales including intersegment sales |
$ | 1,370.6 | $ | 1,165.2 | ||||
Less intersegment sales |
(24.8 | ) | (19.8 | ) | ||||
Net sales |
$ | 1,345.8 | $ | 1,145.4 | ||||
Operating income (1) |
184.9 | 173.1 | ||||||
(1) Included charges associated with restructuring actions in both years, transaction and related costs and gain on sale of product line in 2021. |
$ | .2 | $ | 1.4 |
Three Months Ended October 2, 2021 |
||||
Reported sales change |
18 | % | ||
Foreign currency translation |
(3 | ) | ||
Sales change ex. currency (1) |
15 | |||
Acquisitions and product line divestitures |
(1 | ) | ||
Organic sales change (1) |
14 | % |
Three Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales including intersegment sales |
$ | 541.1 | $ | 433.4 | ||||
Less intersegment sales |
(10.4 | ) | (7.3 | ) | ||||
Net sales |
$ | 530.7 | $ | 426.1 | ||||
Operating income (1) |
58.5 | 47.0 | ||||||
(1) Included charges associated with restructuring actions and gain on investments and transaction and related costs in 2021, and loss on investments in 2020. |
$ | 14.6 | $ | 4.4 |
Three Months Ended October 2, 2021 |
||||
Reported sales change |
25 | % | ||
Foreign currency translation |
(2 | ) | ||
Sales change ex. currency (1) |
22 | |||
Acquisitions |
(9 | ) | ||
Organic sales change (1) |
14 | % |
(1) |
Totals may not sum due to rounding |
Three Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales including intersegment sales |
$ | 199.0 | $ | 159.6 | ||||
Less intersegment sales |
(3.7 | ) | (2.0 | ) | ||||
Net sales |
$ | 195.3 | $ | 157.6 | ||||
Operating income (1) |
18.7 | 12.5 | ||||||
(1) Included charges associated with restructuring actions in both years and transaction and related costs in 2021. |
$ | .7 | $ | 6.6 |
Three Months Ended October 2, 2021 |
||||
Reported sales change |
24 | % | ||
Foreign currency translation |
(4 | ) | ||
Sales change ex. currency (1) |
20 | |||
Acquisitions |
(5 | ) | ||
Organic sales change (1) |
15 | % |
Nine Months Ended |
||||||||
(In millions, except percentages) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales |
$ | 6,225.1 | $ | 4,980.6 | ||||
Cost of products sold |
4,497.4 | 3,628.4 | ||||||
Gross profit |
1,727.7 | 1,352.2 | ||||||
Marketing, general and administrative expense |
916.2 | 758.7 | ||||||
Other expense (income), net |
16.3 | 57.3 | ||||||
Interest expense |
50.2 | 54.4 | ||||||
Other non-operating expense (income), net |
(3.6 | ) | (.2 | ) | ||||
Income before taxes |
$ | 748.6 | $ | 482.0 | ||||
Gross profit margin |
27.8 | % | 27.1 | % |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Other expense (income), net, by type |
||||||||
Restructuring charges: |
||||||||
Severance and related costs |
$ | 5.1 | $ | 46.4 | ||||
Asset impairment charges and lease cancellation costs |
1.9 | 6.2 | ||||||
Other items: |
||||||||
Transaction and related costs |
20.1 | 3.2 | ||||||
Loss on sale of assets, net |
.2 | — | ||||||
(Gain) loss on investment |
(4.9 | ) | 1.5 | |||||
Gain on sale of product line |
(5.7 | ) | — | |||||
Outcomes of legal proceedings, net |
(.4 | ) | — | |||||
Other expense (income), net |
$ | 16.3 | $ | 57.3 |
Nine Months Ended |
||||||||
(In millions, except per share amounts and percentages) |
October 2, 2021 |
September 26, 2020 |
||||||
Income before taxes |
$ | 748.6 | $ | 482.0 | ||||
Provision for (benefit from) income taxes |
187.7 | 114.8 | ||||||
Equity method investment (losses) gains |
(3.5 | ) | (2.8 | ) | ||||
Net income |
$ | 557.4 | $ | 364.4 | ||||
Per share amounts: |
||||||||
Net income per common share |
$ | 6.72 | $ | 4.37 | ||||
Net income per common share, assuming dilution |
6.64 | 4.34 | ||||||
Effective tax rate |
25.1 | % | 23.8 | % |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales including intersegment sales |
$ | 4,170.1 | $ | 3,475.5 | ||||
Less intersegment sales |
(71.1 | ) | (55.1 | ) | ||||
Net sales |
$ | 4,099.0 | $ | 3,420.4 | ||||
Operating income (1) |
639.2 | 483.1 | ||||||
(1) Included charges associated with restructuring actions and transaction and related costs in both years, and outcomes of legal proceedings and gain on sale of product line in 2021. |
$ | (30.2 | ) | $ | 28.3 |
Nine Months Ended October 2, 2021 |
||||
Reported sales change |
20 | % | ||
Foreign currency translation Extra week impact |
|
(5 (1 |
) ) | |
Sales change ex. currency (1) |
13 | |||
Acquisitions and product line divestitures |
(1 | ) | ||
Organic sales change (1) |
12 | % |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales including intersegment sales |
$ | 1,570.8 | $ | 1,142.3 | ||||
Less intersegment sales |
(28.1 | ) | (19.4 | ) | ||||
Net sales |
$ | 1,542.7 | $ | 1,122.9 | ||||
Operating income (1) |
160.6 | 67.2 | ||||||
(1) Included charges associated with restructuring actions and transaction and related costs in both years, outcome of legal proceedings, loss on sale of asset and gain on investments in 2021, and loss on investments in 2020. |
$ | 44.2 | $ | 20.6 |
Nine Months Ended October 2, 2021 |
||||
Reported sales change |
37 | % | ||
Foreign currency translation |
(3 | ) | ||
Extra week impact |
(1 | ) | ||
Sales change ex. currency (1) |
33 | |||
Acquisitions |
(5 | ) | ||
Organic sales change (1) |
28 | % |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net sales including intersegment sales |
$ | 591.4 | $ | 442.1 | ||||
Less intersegment sales |
(8.0 | ) | (4.8 | ) | ||||
Net sales |
$ | 583.4 | $ | 437.3 | ||||
Operating income (1) |
64.7 | 34.9 | ||||||
(1) Included charges associated with restructuring actions in both years and transaction and related costs and gain on sale of assets in 2021. |
$ | 1.3 | $ | 8.6 |
Nine Months Ended October 2, 2021 |
||||
Reported sales change |
33 | % | ||
Foreign currency translation |
(6 | ) | ||
Extra week impact |
(2 | ) | ||
Sales change ex. currency (1) |
25 | |||
Acquisitions |
(5 | ) | ||
Organic sales change (1) |
21 | % |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net income |
$ | 557.4 | $ | 364.4 | ||||
Depreciation |
122.9 | 113.7 | ||||||
Amortization |
48.6 | 36.1 | ||||||
Provision for credit losses and sales returns |
26.1 | 50.4 | ||||||
Stock-based compensation |
27.1 | 12.1 | ||||||
Pension plan settlement loss |
1.0 | — | ||||||
Deferred taxes and other non-cash taxes |
(1.5 | ) | 17.1 | |||||
Other non-cash expense and loss (income and gain), net |
17.7 | 35.3 | ||||||
Changes in assets and liabilities and other adjustments |
(36.5 | ) | (187.3 | ) | ||||
Net cash provided by operating activities |
$ | 762.8 | $ | 441.8 |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Purchases of property, plant and equipment |
$ | (130.6 | ) | $ | (91.7 | ) | ||
Purchases of software and other deferred charges |
(9.8 | ) | (13.8 | ) | ||||
Proceeds from sales of property, plant and equipment |
1.1 | .2 | ||||||
Proceeds from insurance and sales (purchases) of investments, net |
1.2 | 5.2 | ||||||
Proceeds from sale of product line |
6.7 | — | ||||||
Payments for acquisitions, net of cash acquired, and investments in businesses |
(1,474.3 | ) | (262.8 | ) | ||||
Net cash used in investing activities |
$ | (1,605.7 | ) | $ | (362.9 | ) |
Nine Months Ended |
||||||||
(In millions) |
October 2, 2021 |
September 26, 2020 |
||||||
Net increase (decrease) in borrowings with maturities of three months or less |
$ | 332.0 | $ | (57.1 | ) | |||
Additional borrowings under revolving credit facility |
— | 500.0 | ||||||
Repayments of revolving credit facility |
— | (500.0 | ) | |||||
Additional long-term borrowings |
791.9 | 493.7 | ||||||
Repayments of long-term debt and finance leases |
(8.0 | ) | (268.9 | ) | ||||
Dividends paid |
(164.3 | ) | (145.2 | ) | ||||
Share repurchases |
(126.0 | ) | (52.2 | ) | ||||
Net (tax withholding) proceeds related to stock-based compensation |
(25.5 | ) | (20.0 | ) | ||||
Net cash (used in) provided by financing activities |
$ | 800.1 | $ | (49.7 | ) |
(In millions) |
Nine Months Ended October 2, 2021 |
|||
Change in net sales |
$ | 169 |
(In millions, except percentages) |
October 2, 2021 |
September 26, 2020 |
||||||
( |
$ | 169.1 | $ | 558.5 | ||||
Reconciling items: |
||||||||
Cash and cash equivalents |
(207.2 | ) | (284.7 | ) | ||||
Other current assets |
(251.0 | ) | (214.5 | ) | ||||
Short-term borrowings and current portion of long-term debt and finance leases |
398.8 | 124.1 | ||||||
Accrued payroll and employee benefits and other current liabilities |
942.4 | 759.1 | ||||||
( |
$ | 1,052.1 | $ | 942.5 | ||||
( (1) |
$ | 8,523.4 | $ | 6,916.4 | ||||
Operational working capital, as a percentage of annualized current-quarter net sales: (B) ÷ (C) |
12.3 | % | 13.6 | % |
(a) | Not Applicable |
(b) | Not Applicable |
(c) | Repurchases of Equity Securities by Issuer |
Period (1) |
Total number of shares purchased (2) |
Average price paid per share |
Total number of shares purchased as part of publicly announced plans (2)(3) |
Approximate dollar value of shares that may yet be purchased under the plans (4) |
||||||||||||
July 4, 2021 – July 31, 2021 |
75.1 | $ | 206.08 | 75.1 | $ | 429.9 | ||||||||||
August 1, 2021 – August 28, 2021 |
61.9 | 215.37 | 61.9 | 416.6 | ||||||||||||
August 29, 2021 – October 2, 2021 |
9.8 | 215.29 | 9.8 | 414.5 | ||||||||||||
Total |
146.8 | $ | 210.62 | 146.8 | $ | 414.5 |
(1) |
The periods shown are our fiscal periods during the thirteen-week quarter ended October 2, 2021. |
(2) |
Shares in thousands. |
(3) |
In April 2019, our Board authorized the repurchase of shares of our common stock with a fair market value of up to $650 million, exclusive of any fees, commissions or other expenses related to such purchases. This Board authorization will remain in effect until shares in the amount authorized thereunder have been repurchased. |
(4) |
Dollars in millions. |
* | Filed herewith. |
** | Furnished herewith. |
*** | Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, are deemed not filed for purposes of Section 18 of the Exchange Act and otherwise are not subject to liability under those sections. |
AVERY DENNISON CORPORATION |
(Registrant) |
/s/ Gregory S. Lovins |
Gregory S. Lovins |
Senior Vice President and Chief Financial Officer |
(Principal Financial Officer) |
/s/ Lori J. Bondar |
Lori J. Bondar |
Vice President, Controller, Treasurer, and Chief Accounting Officer |
(Principal Accounting Officer) |
November 2, 2021 |
Avery Dennison Corporation
Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Mitchell R. Butier, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
/s/ Mitchell R. Butier |
Mitchell R. Butier |
Chairman, President and Chief Executive Officer |
November 2, 2021
Avery Dennison Corporation
Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION
I, Gregory S. Lovins, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Avery Dennison Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and |
5. | The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): |
a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and |
b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. |
/s/ Gregory S. Lovins |
Gregory S. Lovins |
Senior Vice President and Chief Financial Officer |
November 2, 2021
Avery Dennison Corporation
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the Company) hereby certifies, to the best of his knowledge, that:
(i) | the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended October 2, 2021 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 2, 2021
/s/ Mitchell R. Butier |
Mitchell R. Butier |
Chairman, President and Chief Executive Officer |
* | The above certification accompanies the Companys Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003. |
Avery Dennison Corporation
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER*
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. Section 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Avery Dennison Corporation (the Company) hereby certifies, to the best of his knowledge, that:
(i) | the Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended October 2, 2021 (the Report) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
(ii) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 2, 2021
/s/ Gregory S. Lovins |
Gregory S. Lovins |
Senior Vice President and Chief Financial Officer |
* | The above certification accompanies the Companys Quarterly Report on Form 10-Q and is furnished, not filed, as provided in SEC Release 33-8238, dated June 5, 2003. |